<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.3//EN" "ep-patent-document-v1-3.dtd">
<ep-patent-document id="EP05770962B8W1" file="EP05770962W1B8.xml" lang="fr" country="EP" doc-number="1747201" kind="B8" correction-code="W1" date-publ="20090218" status="c" dtd-version="ep-patent-document-v1-3">
<SDOBI lang="fr"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRISYU........</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  2999001/0</B007EP></eptags></B000><B100><B110>1747201</B110><B120><B121>FASCICULE DE BREVET EUROPEEN CORRIGE</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20090218</date></B140><B150><B151>W1</B151><B153>84</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>05770962.8</B210><B220><date>20050510</date></B220><B240><B241><date>20061211</date></B241><B242><date>20070314</date></B242></B240><B250>fr</B250><B251EP>fr</B251EP><B260>fr</B260></B200><B300><B310>0405055</B310><B320><date>20040511</date></B320><B330><ctry>FR</ctry></B330></B300><B400><B405><date>20090218</date><bnum>200908</bnum></B405><B430><date>20070131</date><bnum>200705</bnum></B430><B450><date>20081015</date><bnum>200842</bnum></B450><B452EP><date>20080116</date></B452EP><B480><date>20090218</date><bnum>200908</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07D 231/54        20060101AFI20060105BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>2H- ODER 3H-BENZO[E]INDAZOL-1-YL-KARBAMAT-DERIVATE, HERSTELLUNG UND THERAPEUTISCHE VERWENDUNG</B542><B541>en</B541><B542>2H OR 3H-BENZO[E]INDAZOL-1-YLE CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF</B542><B541>fr</B541><B542>DERIVES DE CARBAMATE DE 2H- OU 3H-BENZO[E]INDAZOL-1-YLE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE</B542></B540><B560><B561><text>EP-A- 0 607 076</text></B561><B561><text>EP-A- 1 036 794</text></B561><B561><text>WO-A-99/58117</text></B561><B561><text>FR-A- 2 741 073</text></B561><B562><text>YOKOYAMA, NAOKATA ET AL: "2-Arylpyrazolo[4,3-c]quinolin-3-ones: a novel agonist, a partial agonist and an antagonist of benzodiazepines" JOURNAL OF MEDICINAL CHEMISTRY, vol. 25, no. 4, 1982, pages 337-339, XP002312656</text></B562><B562><text>LLOYD G K ET AL: "THE ACTIVITY OF ZOLPIDEM AND OTHER HYPNOTICS WITHIN THE GAMMA-AMINOBUTYRIC ACID (GABAA) RECEPTOR SUPRAMOLECULAR COMPLEX, AS DETERMINED BY 35S-T-BUTYLBICYCLOPHOPHOROTHIONATE (35S-TBPS) BINDING TO RAT CEREBRAL CORTEX MEMBRANES" JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND, US, vol. 255, no. 2, octobre 1990 (1990-10), pages 690-696, XP008001863 ISSN: 0022-3565 &amp; WEISSMAN, BEN A. ET AL: "Presence of peripheral benzodiazepine binding sites on primary rat skeletal fibroblasts" EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 187, no. 3, 1990, pages 369-375, XP002312657</text></B562><B562><text>NAKAO, TOHRU ET AL: "Synthesis and biological activities of optical isomers of 2-(4-chlorophenyl)-5,6-dihydro-(1)benzothi epino[5,4-c]pyridazin- 3(2H)-one 7-oxide" CHEMICAL &amp; PHARMACEUTICAL BULLETIN ( 1992 ), 40 (1), 117 -21 CODEN: CPBTAL; ISSN: 0009-2363, vol. 40, no. 1, 1992, pages 117-121, XP002312658</text></B562><B562><text>PIPERAKI S ET AL: "Enantiomeric separation of zopiclone, its metabolites and products of degradation on a beta-cyclodextrin bonded phase" JOURNAL OF CHROMATOGRAPHY A, ELSEVIER SCIENCE, NL, vol. 729, no. 1, 5 avril 1996 (1996-04-05), pages 19-28, XP004039158 ISSN: 0021-9673</text></B562><B562><text>OLIVIER A ET AL: "A conformational study of ligands for omega modulatory sites of GABAA receptors by noesy NMR spectroscopy and distance geometry" BIOORGANIC &amp; MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 7, no. 17, 9 septembre 1997 (1997-09-09), pages 2277-2282, XP004136428 ISSN: 0960-894X</text></B562><B562><text>RAO, V. L. RAGHAVENDRA ET AL: "Characterization of binding sites for the .omega.3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain" EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 340, no. 1, 1997, pages 89-99, XP002312659</text></B562></B560></B500><B700><B720><B721><snm>DUBOIS, Laurent</snm><adr><str>132, avenue de la Résistance</str><city>F-92350 Le Plessis-Robinson</city><ctry>FR</ctry></adr></B721><B721><snm>EVANNO, Yannick</snm><adr><str>12 rue de Courances</str><city>91490 Dannemois</city><ctry>FR</ctry></adr></B721><B721><snm>MALOIZEL, Christian</snm><adr><str>21, rue du Plateau</str><city>F-92190 Meudon</city><ctry>FR</ctry></adr></B721><B721><snm>SEVRIN, Mireille</snm><adr><str>3, rue Francis de Pressensé</str><city>F-75014 Paris</city><ctry>FR</ctry></adr></B721></B720><B730><B731><snm>Sanofi-Aventis</snm><iid>02783857</iid><irf>SSL0231/AG</irf><adr><str>174, Avenue de France</str><city>75013 Paris</city><ctry>FR</ctry></adr></B731></B730><B740><B741><snm>Morel-Pécheux, Muriel</snm><sfx>et al</sfx><iid>09234011</iid><adr><str>sanofi-aventis 
Département Brevets 
174 avenue de France</str><city>75013 Paris</city><ctry>FR</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20061211</date></B845EP><B845EP><ctry>BA</ctry><date>20061211</date></B845EP><B845EP><ctry>HR</ctry><date>20061211</date></B845EP><B845EP><ctry>LV</ctry><date>20061211</date></B845EP><B845EP><ctry>MK</ctry><date>20061211</date></B845EP><B845EP><ctry>YU</ctry><date>20061211</date></B845EP></B844EP><B860><B861><dnum><anum>FR2005001154</anum></dnum><date>20050510</date></B861><B862>fr</B862></B860><B870><B871><dnum><pnum>WO2005121099</pnum></dnum><date>20051222</date><bnum>200551</bnum></B871></B870><B880><date>20070131</date><bnum>200705</bnum></B880></B800></SDOBI>
</ep-patent-document>
